• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0000
    ---
    High 0.0001
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 1E-06
TimeVolumeKGET
10:13 ET10001E-06
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKGET
Calipharms Inc
13.0K
0.0x
---
United StatesLITH
Bioelife Corp
10.0
0.0x
---
United StatesRTSL
Rapid Therapeutic Science Laboratories Inc
19.0K
0.2x
---
United StatesGHIL
Green and Hill Industries Inc
100.0
0.0x
---
United StatesMDIN
Northstar Global Business Services Inc
40.0
0.0x
---
United StatesBNGI
Bangi Inc
5.6K
0.0x
---
As of 2024-11-26

Company Information

CaliPharms Inc is a developmental stage acquisition company. The Company is focused on acquiring, merging, and joint venturing with legally permitted fully operational marijuana-cannabis businesses. The Company is seeking acquisitions in medical marijuana-cannabis cultivation. The Company focuses on the medical-grade marijuana-cannabis within the State of California. The Company is also expanding into other sectors that support the legalized marijuana industry.

Contact Information

Headquarters
3001 N. Rocky Point Rd., Suite 200TAMPA, FL, United States 33607
Phone
310-227-1772
Fax
302-658-3694

Executives

President, Chief Executive Officer, Director
Bo Linton
Acting Chief Financial Officer, Director
William Wylie
Director
Bryan Geer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$13.0K
Revenue (TTM)
$112.5K
Shares Outstanding
13.0B
Calipharms Inc does not pay a dividend.
Beta
---
EPS
$0.00
Book Value
$0.00
P/E Ratio
0.0x
Price/Sales (TTM)
0.1
Price/Cash Flow (TTM)
---
Operating Margin
-1,069.14%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.